The Chemistry Behind the Cure: Organic Chemistry in Drug Design and Action

The living systems are, at their core, extraordinarily sophisticated organic chemistry laboratories. Every biological process including DNA replication, enzyme catalysis, signal transduction, metabolism is executed through the same functional-group chemistry taught in an introductory organic course: nucleophiles attacking electrophiles, acids donating protons to bases, electrons flowing through conjugated systems. This review examines how organic chemistry principles explain the structure and behaviour of biomolecules, how biological catalysis mirrors and inspires laboratory reactivity, and how this shared chemical language is exploited across the drug development pipeline right from target identification and hit discovery to lead optimization, pharmacokinetics, and clinical translation. The boundary between "organic chemistry" and "biology" is, in a real sense, artificial. Carbohydrates, lipids, proteins, and nucleic acids are organic molecules governed by the same rules of bonding, stereochemistry, and reactivity as any small molecule on a laboratory bench. What makes biological chemistry distinctive is not a different set of rules but an extraordinary degree of control: enzymes accelerate reactions by many times precisely organizing functional groups in three-dimensional space, and biological systems achieve levels of chemo-, regio-, and stereoselectivity that synthetic chemists still strive to match. Drug development sits directly at this interface. A drug is, definitionally, a small organic molecule (or increasingly, a biologic) designed to intervene in a biological process using organic-chemical logic like binding a receptor through hydrogen bonds and van der Waals contacts, inhibiting an enzyme by mimicking its transition state, or undergoing metabolic transformation that activates or deactivates the compound. This review traces that logic from the fundamental organic chemistry of biomolecules through to its application in modern drug discovery.

Authors

Institutions

Publication Details

Journal
Journal of Advanced Chemical Sciences
Published
2026-10-14
DOI
https://doi.org/10.30799/jacs.284.26120504
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Chemistry Behind the Cure: Organic Chemistry in Drug Design and Action

Anandsing Fattesing Patil, Vijay Shivaji Patil, Sandip P. Patil
Journal of Advanced Chemical Sciences
Computational Drug Discovery Methods
article

The Chemistry Behind the Cure: Organic Chemistry in Drug Design and Action

Anandsing Fattesing Patil, Vijay Shivaji Patil, Sandip P. Patil
article en

Abstract

The living systems are, at their core, extraordinarily sophisticated organic chemistry laboratories. Every biological process including DNA replication, enzyme catalysis, signal transduction, metabolism is executed through the same functional-group chemistry taught in an introductory organic course: nucleophiles attacking electrophiles, acids donating protons to bases, electrons flowing through conjugated systems. This review examines how organic chemistry principles explain the structure and behaviour of biomolecules, how biological catalysis mirrors and inspires laboratory reactivity, and how this shared chemical language is exploited across the drug development pipeline right from target identification and hit discovery to lead optimization, pharmacokinetics, and clinical translation. The boundary between "organic chemistry" and "biology" is, in a real sense, artificial. Carbohydrates, lipids, proteins, and nucleic acids are organic molecules governed by the same rules of bonding, stereochemistry, and reactivity as any small molecule on a laboratory bench. What makes biological chemistry distinctive is not a different set of rules but an extraordinary degree of control: enzymes accelerate reactions by many times precisely organizing functional groups in three-dimensional space, and biological systems achieve levels of chemo-, regio-, and stereoselectivity that synthetic chemists still strive to match. Drug development sits directly at this interface. A drug is, definitionally, a small organic molecule (or increasingly, a biologic) designed to intervene in a biological process using organic-chemical logic like binding a receptor through hydrogen bonds and van der Waals contacts, inhibiting an enzyme by mimicking its transition state, or undergoing metabolic transformation that activates or deactivates the compound. This review traces that logic from the fundamental organic chemistry of biomolecules through to its application in modern drug discovery.

Journal of Advanced Chemical SciencesVol. 12(5)
G.S. Science, Arts And Commerce College (IN)
Openalex Percentile: Top 14%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.